Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Total Current Liabilities: 2011-2018

Historic Total Current Liabilities for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to $21.7 million.

  • EyePoint Pharmaceuticals' Total Current Liabilities rose 16.23% to $24.7 million in Q1 2019 from the same period last year, while for Mar 2019 it was $24.7 million, marking a year-over-year increase of 16.23%. This contributed to the annual value of $21.7 million for FY2018, which is 309.51% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Total Current Liabilities of $21.7 million as of FY2018, which was up 309.51% from $5.3 million recorded in FY2017.
  • Over the past 5 years, EyePoint Pharmaceuticals' Total Current Liabilities peaked at $21.7 million during FY2018, and registered a low of $2.1 million during FY2014.
  • Its 3-year average for Total Current Liabilities is $10.7 million, with a median of $5.3 million in 2017.
  • In the last 5 years, EyePoint Pharmaceuticals' Total Current Liabilities crashed by 35.63% in 2014 and then surged by 309.51% in 2018.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Total Current Liabilities stood at $2.1 million in 2014, then spiked by 57.48% to $3.3 million in 2015, then skyrocketed by 52.12% to $5.1 million in 2016, then increased by 3.87% to $5.3 million in 2017, then skyrocketed by 309.51% to $21.7 million in 2018.